Bacil Pharma Acquires 19% Stake in Shree Krishna Infrastructure, Promoter Reduces Holding
Bacil Pharma Limited acquired a 19% stake (20,90,000 shares) in Shree Krishna Infrastructure Limited through an off-market transaction on October 15, 2025. Simultaneously, promoter Prashant Natwarlal Lakhani reduced his holding from 42.78% to 9.48% by selling 36,63,763 shares in the open market. This significant ownership change may impact the company's strategic direction.

*this image is generated using AI for illustrative purposes only.
Shree Krishna Infrastructure Limited has undergone a significant change in its ownership structure, with Bacil Pharma Limited acquiring a substantial stake and a promoter reducing their holding.
Acquisition Details
Bacil Pharma Limited, a non-promoter entity, has acquired a 19% stake in Shree Krishna Infrastructure Limited through an off-market transaction. The details of the acquisition are as follows:
Aspect | Details |
---|---|
Acquirer | Bacil Pharma Limited |
Target Company | Shree Krishna Infrastructure Limited |
Shares Acquired | 20,90,000 |
Stake Percentage | 19% |
Transaction Date | October 15, 2025 |
Transaction Type | Off-market |
Prior Holding | 0 shares |
Promoter Stake Reduction
Simultaneously, a significant change in the promoter holding was observed:
Aspect | Details |
---|---|
Seller | Prashant Natwarlal Lakhani (Promoter) |
Shares Sold | 36,63,763 |
Mode of Sale | Open market |
Date of Sale | October 15, 2025 |
Impact on Shareholding
The transactions have led to a substantial shift in the ownership structure of Shree Krishna Infrastructure Limited:
Shareholder | Before Transaction | After Transaction |
---|---|---|
Bacil Pharma Limited | 0.00% | 19.00% |
Prashant Natwarlal Lakhani | 42.78% | 9.48% |
Company Information
Shree Krishna Infrastructure Limited is listed on the Bombay Stock Exchange Limited with the scrip code 542146. The company has a total equity share capital of 1,10,00,000 shares, each with a face value of Rs. 10.
Regulatory Compliance
Both transactions were reported in compliance with SEBI regulations. Bacil Pharma Limited's acquisition was disclosed under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. The promoter's stake reduction was reported under Regulation 29(2) of the same regulations.
These developments may signal potential changes in the company's strategic direction and warrant attention from investors and market analysts. Stakeholders are advised to monitor further announcements for any impact on the company's operations and governance.
Historical Stock Returns for Shree Krishna Infrastructure
1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|
-4.95% | +6.40% | -27.55% | -57.02% | -77.70% | +261.55% |